Approximately 43,512 bottles of Losartan Potassium (50 mg), a prescription medication used to treat high blood pressure, have been recalled by Hetero Labs Limited. The recall was initiated following a consumer complaint about a 'bulging' tablet, which indicates the product failed to meet physical quality and appearance specifications. These affected 90-count bottles were manufactured for Camber Pharmaceuticals and distributed to major wholesalers and distributors across the United States. While no specific injuries have been reported, consumers should check their medication bottles immediately for the affected batch number.
The tablets failed to meet the required physical specifications, as evidenced by a report of a bulging tablet. This defect may affect the consistency, dosage, or stability of the medication, potentially impacting its effectiveness in managing blood pressure.
Contact your healthcare provider or pharmacist for guidance.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.